SAN DIEGO, April 18, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Chiasma, Inc. (NASDAQ: CHMA) and certain of its officers and directors. Chiasma is a late-stage biopharmaceutical company that focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases.
Specifically, Johnson & Weaver's investigation seeks to determine whether the Company's filings with the U.S. Securities and Exchange Commission in connection with its July 2015 initial public stock offering (the "IPO") contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company's business and financial prospects.
In July 2015, Chiasma offered more than 6,300,000 shares of its common stock at $16.00 per share in connection with its IPO. Chiasma shares are plunging and were trading below $4.50 per share during pre-market trading on April 18, 2016. The stock dropped following the U.S. Food and Drug Administration rejection of the Company's drug to treat acromegaly, a rare disease of the pituitary gland.
If you have information that could assist in this investigation, or if you are a Chiasma shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (email@example.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
SOURCE Johnson & Weaver, LLP